Q BioMed Inc. ''Q`` is a biomedical acceleration and development company. We are focused on licensing and acquiring undervalued and under-appreciated biomedical assets. Q is dedicated to providing these target assets, the strategic resources, developmental support, and expansion capital to ensure they meet their potential. The end result being value recognition and ultimately enabling them to provide products to patients in need‏.

“Our vision is to create a pipeline of innovative biomedical assets in various stages of development in multiple therapeutic areas. This strategy is designed to minimize risk, share success and ensure consistent advancement in milestone achievements.”



CEO Denis Corin Interview

Watch Here

The right firm

Q focuses exclusively in the biotechnology and healthcare sectors, targeting a broad spectrum of biomedical products and healthcare solutions. Q’s expertise is in business & product development and the capital formation required for phased advancement of products.

The right solution

Our team aims to assist companies by utilizing our investment partners and network of experts to provide public market access to private company assets.

The right strategy

Q expects to maximize risk-adjusted returns by focusing on clincal stage and near revenue businesses where the technical, regulatory, and commercial risks have been mitigated or where major valuation inflections are imminent.

Social media & sharing icons powered by UltimatelySocial